Hypera S.A. (HYPE3.SA)

28.40 +0.10 (+0.35%) At close: 05:07PM BRT

Hypera S.A.

Av. Magalhães de Castro, 4800
240 Floor Continental Tower Building Bairro Cidade Jardim
São Paulo, SP 05676-120
Brazil
55 11 3627 4206
https://www.hyperapharma.com.br

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 10,301

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Breno Toledo Pires de Oliveira	CEO & Director	N/A	N/A	N/A
Mr. Adalmario Ghovatto Satheler do Couto	Investor Relations Officer & CFO	N/A	N/A	N/A
Mr. Carlos Roberto Scorsi	Chief Operating officer	N/A	N/A	1962
Juliana Aguinaga Damião Salem	Senior Legal Officer & Director	N/A	N/A	N/A
Joao Felipe Khamis Aguilar	Risks & Compliance Officer	N/A	N/A	N/A
Mr. Luiz Eduardo Sales Clavis	VP of Sales and Marketing & Director	N/A	N/A	N/A
Mauricio Christovam	Senior Human Resources Officer	N/A	N/A	N/A
Mr. Hélio Segouras	Head of Consumer Health	N/A	N/A	N/A

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in BRL.

Description

Hypera S.A. operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex – A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands. The company also provides sun protection and moisturizing skin care products under the Mantecorp Skincare brands; similar products under the Doralgina, Dropy D, balance, Flavonid, histamin, NeoFresh, neolefrin, Neochemistry Vitamins, Neosorum, and Torsilax brand names; and consumer health products under the Apracur, Benegrip, Buscopan, Coristina D Pro, Engov, Epocler, Estomazil, and Neosaldina brands, as well as similar and generic drugs under the Neo Química brand. In addition, it offers nutritional and vitamin supplement products under the Tamarine, Vitasay, Biotônico Fontoura, and Zero-Cal brands; and generic medicines under the Hydroxyzine, Sodium Diclofenac, Dipyron, Ibuprofen, Losartan Potassium, Mal Dexchlorpheniramine, Naproxene, Paracetamol, Simethicon, Loratadine, Omeprazole, Tadalaphyl, and Desogestrel brand names. The company was formerly known as Hypermarcas S.A. and changed its name to Hypera S.A. in February 2018. Hypera S.A. was founded in 2001 and is headquartered in São Paulo, Brazil.

Corporate governance

Hypera S.A.’s ISS governance QualityScore as of 1 April 2024 is 5. The pillar scores are Audit: 4; Board: 7; Shareholder rights: 1; Compensation: 7.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.